Understanding how osteoblast development affects Osteogenesis Imperfecta Type V
INVESTIGATING THE CONTRIBUTION OF OSTEOBLAST DIFFERENTIATION IN THE PATHOGENESIS OF OSTEOGENESIS IMPERFECTA TYPE V
This study is looking at how a specific genetic change affects bone-building cells in people with Osteogenesis Imperfecta Type V, with the hope of finding better treatments to help strengthen their bones.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baylor College of Medicine NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11070589 on NIH RePORTER |
What this research studies
This research investigates the role of osteoblast differentiation in Osteogenesis Imperfecta Type V (OI-V), a genetic condition that leads to fragile bones. The study focuses on a specific genetic mutation that alters the function of a protein involved in bone formation. By exploring how this mutation affects osteoblasts, the research aims to identify new therapeutic approaches that could improve treatment outcomes for patients with OI-V. The ultimate goal is to develop targeted therapies that address the unique challenges faced by these patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Osteogenesis Imperfecta Type V, particularly those with the specific genetic mutation being studied.
Not a fit: Patients with other types of Osteogenesis Imperfecta or those without the specific genetic mutation associated with OI-V may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for Osteogenesis Imperfecta Type V, improving bone health and reducing fractures in affected patients.
How similar studies have performed: Previous research has shown promise in understanding genetic contributions to Osteogenesis Imperfecta, but this specific approach to OI-V is relatively novel.
Where this research is happening
Houston, United States
- Baylor College of Medicine — Houston, United States (Active)
Researchers
- Principal investigator: Busse, Emily — Baylor College of Medicine
- Study coordinator: Busse, Emily
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.